Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China
· Delayed Price · Currency is CNY 8.39
+0.04 (0.48%)
May 14, 2025, 2:45 PM CST
SHE:300009 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,506 | 2,533 | 2,861 | 2,327 | 2,160 | 1,694 | Upgrade
|
| Other Revenue | 2.65 | 2.65 | 4.57 | 4.18 | 8.5 | 7.69 | Upgrade
|
| Revenue | 2,509 | 2,536 | 2,866 | 2,331 | 2,169 | 1,701 | Upgrade
|
| Revenue Growth (YoY) | -14.31% | -11.51% | 22.94% | 7.48% | 27.47% | -0.65% | Upgrade
|
| Cost of Revenue | 578.01 | 581.16 | 626.15 | 513.47 | 436.15 | 364.09 | Upgrade
|
| Gross Profit | 1,931 | 1,955 | 2,240 | 1,818 | 1,733 | 1,337 | Upgrade
|
| Selling, General & Admin | 972.23 | 986.63 | 1,035 | 871.18 | 942.68 | 791.65 | Upgrade
|
| Research & Development | 198.02 | 201.29 | 254.68 | 166.01 | 166.54 | 128.76 | Upgrade
|
| Other Operating Expenses | -3.18 | 0.32 | 17.21 | 19.32 | 19.47 | 16.38 | Upgrade
|
| Operating Expenses | 1,179 | 1,195 | 1,327 | 1,062 | 1,133 | 940.64 | Upgrade
|
| Operating Income | 752.05 | 759.46 | 912.92 | 755.7 | 599.3 | 396.69 | Upgrade
|
| Interest Expense | -2.1 | -2.4 | -1.87 | -1.52 | -1.62 | -1.62 | Upgrade
|
| Interest & Investment Income | 24.87 | 20.42 | 5.89 | 9.61 | 11.52 | 13.6 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.08 | 0.08 | 0.86 | 0.06 | 3.92 | -0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.35 | -2.79 | -1.11 | 26.47 | -12.29 | -16.26 | Upgrade
|
| EBT Excluding Unusual Items | 769.54 | 774.76 | 916.69 | 790.32 | 600.83 | 392.35 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -322.6 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.04 | 10.52 | -15.44 | 19.86 | -2.24 | -15.42 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.22 | 1.09 | 0.12 | -1.2 | 1.68 | -0.02 | Upgrade
|
| Asset Writedown | -0.08 | -0.15 | -1.49 | -4.47 | -0.84 | -0.03 | Upgrade
|
| Other Unusual Items | 17.54 | 16.8 | 20.05 | 29.34 | 18.28 | 39.27 | Upgrade
|
| Pretax Income | 793.26 | 803.02 | 919.93 | 833.85 | 295.12 | 416.14 | Upgrade
|
| Income Tax Expense | 86.05 | 87.18 | 61.34 | 96.19 | 91.73 | 69.6 | Upgrade
|
| Earnings From Continuing Operations | 707.21 | 715.84 | 858.59 | 737.66 | 203.39 | 346.53 | Upgrade
|
| Minority Interest in Earnings | -9.01 | -8.89 | -11.36 | -34.4 | 3.24 | 12.42 | Upgrade
|
| Net Income | 698.2 | 706.95 | 847.23 | 703.26 | 206.63 | 358.96 | Upgrade
|
| Net Income to Common | 698.2 | 706.95 | 847.23 | 703.26 | 206.63 | 358.96 | Upgrade
|
| Net Income Growth | -20.60% | -16.56% | 20.47% | 240.35% | -42.44% | 188.40% | Upgrade
|
| Shares Outstanding (Basic) | 1,673 | 1,674 | 1,674 | 1,635 | 1,589 | 1,632 | Upgrade
|
| Shares Outstanding (Diluted) | 1,673 | 1,674 | 1,674 | 1,635 | 1,589 | 1,632 | Upgrade
|
| Shares Change (YoY) | -0.08% | 0.02% | 2.34% | 2.90% | -2.58% | -1.68% | Upgrade
|
| EPS (Basic) | 0.42 | 0.42 | 0.51 | 0.43 | 0.13 | 0.22 | Upgrade
|
| EPS (Diluted) | 0.42 | 0.42 | 0.51 | 0.43 | 0.13 | 0.22 | Upgrade
|
| EPS Growth | -20.54% | -16.57% | 17.72% | 230.77% | -40.91% | 193.33% | Upgrade
|
| Free Cash Flow | 641.78 | 568.15 | 757.64 | 224.64 | 460.94 | 326.27 | Upgrade
|
| Free Cash Flow Per Share | 0.38 | 0.34 | 0.45 | 0.14 | 0.29 | 0.20 | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | 0.250 | 0.250 | 0.200 | 0.167 | Upgrade
|
| Dividend Growth | - | - | - | 25.00% | 19.98% | 73.28% | Upgrade
|
| Gross Margin | 76.96% | 77.08% | 78.15% | 77.97% | 79.89% | 78.60% | Upgrade
|
| Operating Margin | 29.98% | 29.95% | 31.86% | 32.42% | 27.63% | 23.32% | Upgrade
|
| Profit Margin | 27.83% | 27.88% | 29.56% | 30.17% | 9.53% | 21.10% | Upgrade
|
| Free Cash Flow Margin | 25.58% | 22.40% | 26.44% | 9.64% | 21.25% | 19.18% | Upgrade
|
| EBITDA | 840.19 | 846.07 | 993.44 | 836.21 | 676.71 | 462.67 | Upgrade
|
| EBITDA Margin | 33.49% | 33.36% | 34.67% | 35.87% | 31.20% | 27.19% | Upgrade
|
| D&A For EBITDA | 88.13 | 86.61 | 80.52 | 80.5 | 77.41 | 65.99 | Upgrade
|
| EBIT | 752.05 | 759.46 | 912.92 | 755.7 | 599.3 | 396.69 | Upgrade
|
| EBIT Margin | 29.98% | 29.95% | 31.86% | 32.42% | 27.63% | 23.32% | Upgrade
|
| Effective Tax Rate | 10.85% | 10.86% | 6.67% | 11.54% | 31.08% | 16.73% | Upgrade
|
| Revenue as Reported | 2,509 | 2,536 | 2,866 | 2,331 | 2,169 | 1,701 | Upgrade
|
| Advertising Expenses | - | 33.44 | 11.12 | 8.24 | 9.96 | 6 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.